Cargando…

An Observational Study from Long-Term AAV Re-administration in Two Hemophilia Dogs

Adeno-associated virus (AAV) vectors have been successfully applied in hemophilia clinical trials. However, this approach is limited to patients without AAV-neutralizing antibodies (NAbs). In this study, we explored the feasibility of AAV re-administration in hemophilia A dogs treated initially 8 ye...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Junjiang, Shao, Wenwei, Chen, Xiaojing, Merricks, Elizabeth P., Wimsey, Lauren, Abajas, Yasmina L., Niemeyer, Glenn P., Lothrop, Clinton D., Monahan, Paul E., Samulski, R. Jude, Nichols, Timothy C., Li, Chengwen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104583/ https://www.ncbi.nlm.nih.gov/pubmed/30140713 http://dx.doi.org/10.1016/j.omtm.2018.07.011

Ejemplares similares

Chimeric Mice Engrafted With Canine Hepatocytes Exhibits Similar AAV Transduction Efficiency to Hemophilia B Dog
por: Shao, Wenwei, et al.
Publicado: (2022)

Development of AAV Variants with Human Hepatocyte Tropism and Neutralizing Antibody Escape Capacity
por: Pei, Xiaolei, et al.
Publicado: (2020)

Direct Interaction of Human Serum Proteins with AAV Virions to Enhance AAV Transduction: Immediate Impact on Clinical Applications
por: Wang, Mei, et al.
Publicado: (2016)

Superior human hepatocyte transduction with Adeno-associated Virus Vector Serotype 7
por: Shao, Wenwei, et al.
Publicado: (2019)

AAV Recombineering with Single Strand Oligonucleotides
por: Hirsch, Matthew L., et al.
Publicado: (2009)

A long-term study of AAV gene therapy in hemophilia A dogs identifies clonal expansions of transduced liver cells
por: Nguyen, Giang N., et al.
Publicado: (2020)

Adeno-associated virus-mediated expression of activated factor V (FVa) for hemophilia phenotypic correction
por: Sun, Junjiang, et al.
Publicado: (2022)

Oral Tolerance Induction in Hemophilia B Dogs Fed with Transplastomic Lettuce
por: Herzog, Roland W., et al.
Publicado: (2017)

Employing a Gain-of-Function Factor IX Variant R338L to Advance the Efficacy and Safety of Hemophilia B Human Gene Therapy: Preclinical Evaluation Supporting an Ongoing Adeno-Associated Virus Clinical Trial
por: Monahan, Paul E., et al.
Publicado: (2015)

Adeno-Associated Virus (AAV) Versus Immune Response
por: Rabinowitz, Joseph, et al.
Publicado: (2019)

Safety of AAV Factor IX Peripheral Transvenular Gene Delivery to Muscle in Hemophilia B Dogs
por: Haurigot, Virginia, et al.
Publicado: (2010)

Global CNS Gene Delivery and Evasion of Anti-AAV Neutralizing Antibodies by Intrathecal AAV Administration in Non-Human Primates
por: Gray, Steven J., et al.
Publicado: (2013)

Preclinical toxicity evaluation of AAV for pain: evidence from human AAV studies and from the pharmacology of analgesic drugs
por: Pleticha, Josef, et al.
Publicado: (2014)

Molecular evaluation and vector integration analysis of HCC complicating AAV gene therapy for hemophilia B
por: Schmidt, Manfred, et al.
Publicado: (2023)

Evaluation of engineered AAV capsids for hepatic factor IX gene transfer in murine and canine models
por: Markusic, David M., et al.
Publicado: (2017)

AAV Gene Therapy for MPS1-associated Corneal Blindness
por: Vance, Melisa, et al.
Publicado: (2016)

Global Seroprevalence of Pre-existing Immunity Against AAV5 and Other AAV Serotypes in People with Hemophilia A
por: Klamroth, Robert, et al.
Publicado: (2022)

Efficient Capsid Antigen Presentation From Adeno-Associated Virus Empty Virions In Vivo
por: Pei, Xiaolei, et al.
Publicado: (2018)

Corrigendum: Efficient Capsid Antigen Presentation From Adeno-Associated Virus Empty Virions In Vivo
por: Pei, Xiaolei, et al.
Publicado: (2020)

AAV Exploits Subcellular Stress Associated with Inflammation, Endoplasmic Reticulum Expansion, and Misfolded Proteins in Models of Cystic Fibrosis
por: Johnson, Jarrod S., et al.
Publicado: (2011)

Mechanisms of Foreign Body Response Mitigation by Nitric Oxide Release
por: Taylor, James B., et al.
Publicado: (2022)

Efficient gene transduction in pigs and macaques with the engineered AAV vector AAV.GT5 for hemophilia B gene therapy
por: Kashiwakura, Yuji, et al.
Publicado: (2023)

Thermostability and in vivo performance of AAV9 in a film matrix
por: Doan, Trang Nguyen Kieu, et al.
Publicado: (2022)

Low-dose AAV-CRISPR-mediated liver-specific knock-in restored hemostasis in neonatal hemophilia B mice with subtle antibody response
por: He, Xiangjun, et al.
Publicado: (2022)

Prediction of Adeno-Associated Virus Neutralizing Antibody Activity for Clinical Application
por: Wang, Mei, et al.
Publicado: (2015)

Three-dimensional multipotent progenitor cell aggregates for expansion, osteogenic differentiation and “in vivo” tracing with AAV vector serotype 6
por: Ferreira, Joäo R., et al.
Publicado: (2012)

Preclinical biodistribution, tropism, and efficacy of oligotropic AAV/Olig001 in a mouse model of congenital white matter disease
por: Francis, Jeremy S., et al.
Publicado: (2021)

Procoagulant Microparticles in Dogs with Immune‐Mediated Hemolytic Anemia
por: Kidd, L., et al.
Publicado: (2015)

Sub-2 Å Ewald curvature corrected structure of an AAV2 capsid variant
por: Tan, Yong Zi, et al.
Publicado: (2018)

Development of an AAV DNA-based synthetic vector for the potential gene therapy of hemophilia in children
por: Shoti, Jakob, et al.
Publicado: (2022)

Adenovirus‐associated antibodies in UK cohort of hemophilia patients: A seroprevalence study of the presence of adenovirus‐associated virus vector–serotypes AAV5 and AAV8 neutralizing activity and antibodies in patients with hemophilia A
por: Stanford, Sophia, et al.
Publicado: (2019)

Hemophilia A and B mice, but not VWF(−/−)mice, display bone defects in congenital development and remodeling after injury
por: Taves, Sarah, et al.
Publicado: (2019)

Global measurement of coagulation in plasma from normal and haemophilia dogs using a novel modified thrombin generation test – Demonstrated in vitro and ex vivo
por: Madsen, Daniel Elenius, et al.
Publicado: (2017)

Chimeric Capsid Proteins Impact Transduction Efficiency of Haploid Adeno-Associated Virus Vectors
por: Chai, Zheng, et al.
Publicado: (2019)

Intra-articular delivery of AAV vectors encoding PD-L1 attenuates joint inflammation and tissue damage in a mouse model of rheumatoid arthritis
por: Li, Wenjun, et al.
Publicado: (2023)

Pharmacological Modulation of Humoral Immunity in a Nonhuman Primate Model of AAV Gene Transfer for Hemophilia B
por: Mingozzi, Federico, et al.
Publicado: (2012)

Overexpression of factor VIII after AAV delivery is transiently associated with cellular stress in hemophilia A mice
por: Lange, Amy M, et al.
Publicado: (2016)

Preclinical assessment of an optimized AAV-FVIII vector in mice and non-human primates for the treatment of hemophilia A
por: Elkouby, Liron, et al.
Publicado: (2021)

Early Phase Clinical Immunogenicity of Valoctocogene Roxaparvovec, an AAV5-Mediated Gene Therapy for Hemophilia A
por: Long, Brian R., et al.
Publicado: (2021)

Retinal pigment epithelial cell expression of active Rap 1a by scAAV2 inhibits choroidal neovascularization
por: Wang, Haibo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8b058bk7uvji9qbt0qu6vtutus